Le Lézard
Classified in: Health, Business
Subjects: LEG, POL, AVO

Blue Cross Blue Shield Association Applauds Extension of Affordable Care Act Tax Credits

WASHINGTON, Aug. 7, 2022 /PRNewswire/ -- Blue Cross Blue Shield Association President and CEO Kim Keck issued the following statement today in response to the passage of the Inflation Reduction Act, which extends Affordable Care Act (ACA) tax credits for three years.

"The Senate's extension of these tax credits will protect nearly 13 million Americans from cost increases at a time when the price of everything?from gas to groceries?is rising. This move keeps real money in the pocketbooks of Americans and gives them real peace of mind. We look forward to the House passing and the president signing this bill into law and will continue to work with Congress to make health care more affordable for everyone."

About Blue Cross Blue Shield Association
The Blue Cross and Blue Shield Association is a national federation of 34 independent, community-based and locally operated Blue Cross and Blue Shield companies that collectively provide health care coverage for one in three Americans.

SOURCE Blue Cross Blue Shield Association

These press releases may also interest you

at 03:00

at 03:00
CSL Vifor and Travere Therapeutics, Inc., today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the...

at 03:00
Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration aimed at developing a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies' pipeline candidates. The...

at 02:45
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2024....

at 02:25
SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce a new partnership with Al Shirawi Healthcare solutions, a leading distributor of medical technologies...

at 02:20
BioInvent International (STO:BINV)"During the first quarter of the year, we continued making excellent progress with our clinical pipeline targeting TNFR2 and FcyRIIB, building on the momentum we generated during a very successful 2023. Looking...

News published on and distributed by: